Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 1,943,682 | +1,943,682 | 0 | 20,564 | 8.67% | +20,564 |
| CYTOKINETICS INC(CYTK) | 458,295 | 503,295 | +45,000 | 29,120 | 33,172 | 13.99% | +4,052 |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | 132,606 | 134,995 | 56.94% | +2,389 |
| Alector, Inc. | 3,887,200 | 3,887,200 | 0 | 6,064 | 8,357 | 3.53% | +2,293 |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | 7,171 | 9,304 | 3.92% | +2,133 |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | 8,460 | 9,950 | 4.20% | +1,490 |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 800,399 | 0 | 24,636 | 16,056 | 6.77% | -8,580 |
| Maze Therapeutics, Inc.(MAZE) | 522,657 | 156,901 | -365,756 | 21,654 | 4,683 | 1.98% | -16,970 |